IGF1 and cancer: These experiments in mice effectively demonstrated the potent inhibition of the Gh1r/Igf1 pathway, whether in cancer cells or in the supporting microenvironmental cells, leading to the inhibition of cancer cell growth, reduced inflammatory infiltration, enhanced apoptosis, reduced proliferation, and metastatic arrest.